Mammary epithelial cell: influence of extracellular matrix composition and organization during development and tumorigenesis.

Stromal-epithelial interactions regulate mammary gland development and are critical for the maintenance of tissue homeostasis. The extracellular matrix, which is a proteinaceous component of the stroma, regulates mammary epithelial growth, survival, migration and differentiation through a repertoire of transmembrane receptors, of which integrins are the best characterized. Integrins modulate cell fate by reciprocally transducing biochemical and biophysical cues between the cell and the extracellular matrix, facilitating processes such as embryonic branching morphogenesis and lactation in the mammary gland. During breast development and cancer progression, the extracellular matrix is dynamically altered such that its composition, turnover, processing and orientation change dramatically. These modifications influence mammary epithelial cell shape, and modulate growth factor and hormonal responses to regulate processes including branching morphogenesis and alveolar differentiation. Malignant transformation of the breast is also associated with significant matrix remodeling and a progressive stiffening of the stroma that can enhance mammary epithelial cell growth, perturb breast tissue organization, and promote cell invasion and survival. In this review, we discuss the role of stromal-epithelial interactions in normal and malignant mammary epithelial cell behavior. We specifically focus on how dynamic modulation of the biochemical and biophysical properties of the extracellular matrix elicit a dialogue with the mammary epithelium through transmembrane integrin receptors to influence tissue morphogenesis, homeostasis and malignant transformation.

[1]  R. Weinberg,et al.  Reconstruction of functionally normal and malignant human breast tissues in mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[2]  C. Streuli,et al.  Rac1 links integrin-mediated adhesion to the control of lactational differentiation in mammary epithelia , 2006, The Journal of cell biology.

[3]  S. Santoro,et al.  The alpha(2) integrin subunit-deficient mouse: a multifaceted phenotype including defects of branching morphogenesis and hemostasis. , 2002, The American journal of pathology.

[4]  C. Larabell,et al.  Reversion of the Malignant Phenotype of Human Breast Cells in Three-Dimensional Culture and In Vivo by Integrin Blocking Antibodies , 1997, The Journal of cell biology.

[5]  B. Kaina,et al.  Rho GTPases are over‐expressed in human tumors , 1999, International journal of cancer.

[6]  J. Segall,et al.  Intravital imaging of cell movement in tumours , 2003, Nature Reviews Cancer.

[7]  J. Pollard.  Tumour-educated macrophages promote tumour progression and metastasis , 2004, Nature Reviews Cancer.

[8]  A. Sonnenberg,et al.  Epithelial Development and Differentiation in the Mammary Gland Is Not Dependent on α3 or α6 Integrin Subunits , 2001 .

[9]  T. Sakakura,et al.  Participation of two different mesenchymes in the developing mouse mammary gland: synthesis of basement membrane components by fat pad precursor cells. , 1985, Journal of embryology and experimental morphology.

[10]  Joe W Gray,et al.  Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo. , 2006, Cancer research.

[11]  T. Sakakura,et al.  Mesenchyme-dependent morphogenesis and epithelium-specific cytodifferentiation in mouse mammary gland. , 1976, Science.

[12]  Quynh-Thu Le,et al.  Lysyl oxidase is essential for hypoxia-induced metastasis , 2006, Nature.

[13]  J. Thiery,et al.  Mouse embryonic mammogenesis as a model for the molecular regulation of pattern formation. , 2003, Differentiation; research in biological diversity.

[14]  G. Inghirami,et al.  β4 Integrin Amplifies ErbB2 Signaling to Promote Mammary Tumorigenesis , 2006, Cell.

[15]  Mina J Bissell,et al.  Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes , 2003, Breast Cancer Research.

[16]  J. Thiery,et al.  Integrins in Mammary Gland Development and Differentiation of Mammary Epithelium , 2003, Journal of Mammary Gland Biology and Neoplasia.

[17]  R. Warren,et al.  Mammographic patterns as a predictive biomarker of breast cancer risk: effect of tamoxifen. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[18]  M. Sheetz,et al.  Cell migration: regulation of force on extracellular-matrix-integrin complexes. , 1998, Trends in cell biology.

[19]  Joyce Y. Wong,et al.  Directed Movement of Vascular Smooth Muscle Cells on Gradient-Compliant Hydrogels† , 2003 .

[20]  G. Giannelli,et al.  Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. , 1997, Science.

[21]  Matthew J. Paszek,et al.  The Tension Mounts: Mechanics Meets Morphogenesis and Malignancy , 2004, Journal of Mammary Gland Biology and Neoplasia.

[22]  T. Pawson,et al.  Discoidin Domain Receptor 1 Tyrosine Kinase Has an Essential Role in Mammary Gland Development , 2001, Molecular and Cellular Biology.

[23]  Cynthia A. Reinhart-King,et al.  Tensional homeostasis and the malignant phenotype. , 2005, Cancer cell.

[24]  A. Sonnenberg,et al.  Epithelial development and differentiation in the mammary gland is not dependent on the laminin receptors, alpha 6, alpha 3 and beta 4 integrin. , 2001 .

[25]  S. Merajver,et al.  WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer , 2003, Breast Cancer Research.

[26]  W. Muller,et al.  Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. , 2004, Cancer cell.

[27]  T. Sakakura,et al.  Dual origin of mesenchymal tissues participating in mouse mammary gland embryogenesis. , 1982, Developmental biology.

[28]  A. Blidaru,et al.  MMP-9 and MMP-2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast cancer: correlations with prognostic factors , 2006, Journal of cellular and molecular medicine.

[29]  N. Hynes,et al.  Ablation of β1 integrin in mammary epithelium reveals a key role for integrin in glandular morphogenesis and differentiation , 2005, The Journal of cell biology.

[30]  S. Haslam,et al.  Fibronectin and the α5β1 Integrin Are Under Developmental and Ovarian Steroid Regulation in the Normal Mouse Mammary Gland. , 2001, Endocrinology.

[31]  F. Talamantes,et al.  Mammary phenotypic expression induced in epidermal cells by embryonic mammary mesenchyme. , 1995, Acta anatomica.

[32]  F. Stossi,et al.  Kinase-specific phosphorylation of the estrogen receptor changes receptor interactions with ligand, deoxyribonucleic acid, and coregulators associated with alterations in estrogen and tamoxifen activity. , 2006, Molecular endocrinology.